Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bone Marrow Transplant ; 26(3): 357-63, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10967581

RESUMEN

Infantile ceramidase deficiency (Farber disease) is an uncommon, progressive lysosomal storage disease characterized by multiple ceramide-containing nodules (lipogranulomata) in the subcutaneous tissue and upper aerodigestive tract, painful periarticular swelling, psychomotor retardation, and varying degrees of ocular, pulmonary or hepatic involvement. Management of Farber disease has been limited to symptomatic supportive care, and few affected infants survive beyond 5 years of age. We performed an allogeneic bone marrow transplant (BMT) from an HLA-identical heterozygous sister in a 9.5-month-old female with minimally symptomatic Farber disease who received a pre-transplant regimen of busulfan and cyclophosphamide. Ceramidase activity in peripheral blood leukocytes increased from 6% before transplant to 44% (donor heterozygote level) by 6 weeks after BMT. By 2 months after transplant, the patient's subcutaneous lipogranulomata, pain on joint motion, and hoarseness had resolved. Despite modest gains in cognitive and language development, hypotonia and delayed motor skills persisted. Gradual loss of circulating donor cells with autologous hematopoietic recovery occurred; VNTR analyses showed 50% donor DNA in peripheral blood cells at 8.5 months after BMT and only 1% at 21 months after transplant. Interestingly, leukocyte ceramidase activity consistently remained in the heterozygous range despite attrition of donor cells in peripheral blood. This novel observation indicates ongoing hydrolase production by non-circulating donor cells, possibly in the mononuclear phagocytic system, and uptake by recipient leukocytes. Although lipogranulomata and hoarseness did not recur, the patient's neurological and neurocognitive status progressively declined. She died 28 months after BMT (age 37.5 months) with pulmonary insufficiency caused by recurrent aspiration pneumonias. Allogeneic BMT improves the peripheral manifestations of infantile ceramidase deficiency, but may not prevent the progressive neurological deterioration, even when carried out in minimally symptomatic patients.


Asunto(s)
Trasplante de Médula Ósea , Galactosilgalactosilglucosilceramidasa/deficiencia , Enfermedades por Almacenamiento Lisosomal/terapia , Busulfano/farmacocinética , Preescolar , Discapacidades del Desarrollo/etiología , Femenino , Galactosilgalactosilglucosilceramidasa/sangre , Humanos , Inmunosupresores/farmacocinética , Lactante , Leucocitos/enzimología , Enfermedades por Almacenamiento Lisosomal/enzimología , Fibras Nerviosas Mielínicas/metabolismo , Sistema Nervioso/crecimiento & desarrollo
3.
Vopr Med Khim ; 32(5): 120-3, 1986.
Artículo en Ruso | MEDLINE | ID: mdl-3095985

RESUMEN

Activity of several lysosomal enzymes was studied in leukocytes, blood plasma and skin fibroblasts of two adult brothers with clinical diagnosis of Fabry disease. Activity of ceramide trihexoside-galactosidase was distinctly decreased in both patients. The residual enzymatic activity constituted 5-6% in the patients leukocytes, less than 10% in blood plasma and 25% in fibroblasts as compared with controls. Differences in composition of alpha-D-galactosidase multiple forms were detected in fibroblasts and blood cells of the patients with Fabry disease as compared with normal leukocytes by means of isoelectric focusing.


Asunto(s)
Pruebas Enzimáticas Clínicas , Enfermedad de Fabry/diagnóstico , Galactosidasas/deficiencia , Galactosilgalactosilglucosilceramidasa/deficiencia , Enfermedad de Fabry/genética , Galactosilgalactosilglucosilceramidasa/sangre , Humanos , Focalización Isoeléctrica , Leucocitos/enzimología , Masculino , Persona de Mediana Edad , Piel/enzimología
4.
Clin Chim Acta ; 89(1): 35-45, 1978 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-101320

RESUMEN

Trihexosylceramide, isolated from human kidney and labelled in the terminal galactose position by oxidation with galactose oxidase and reduction with sodium boro[3H]hydride, was used to study some of the properties of human leucocyte alpha-galactosidase. The enzyme was inactive in the absence of detergent. Of all the detergents tested a crude sodium taurocholate preparation displayed the greatest activity. The optimal detergent concentration varied from 2 to 4 mg/ml depending on the protein concentration and indicating that the enzyme activity was dependent on the protein/detergent ratio. Because of its influence in regulating enzyme activity, it is essential that care must be taken to ensure that the protein/detergent ratio of all incubation mixtures is kept relatively constant whenever the diagnosis of Fabry's disease is attempted.


Asunto(s)
Galactosidasas/sangre , Galactosilgalactosilglucosilceramidasa/sangre , Glicoesfingolípidos/sangre , Leucocitos/enzimología , Trihexosilceramidas/sangre , Pruebas Enzimáticas Clínicas , Detergentes , Enfermedad de Fabry/diagnóstico , Femenino , Galactosilgalactosilglucosilceramidasa/antagonistas & inhibidores , Humanos , Lípidos/sangre , Masculino , Factores de Tiempo
5.
Nouv Presse Med ; 5(40): 2697-700, 1976 Nov 27.
Artículo en Francés | MEDLINE | ID: mdl-826883

RESUMEN

On the basis of a study of 9 new cases of Fabry's disease (7 hemizygotes and 2 heterozygotes), the authors recall that the disease often presents as a painful syndrome of the extremities but its exact nature usually remains obscure for long periods. The association of such pain with angiokeratomas and the notion of a family history is highly suggestive of the disease. The biochemical possibilities in the diagnosis of the latter are described. All patients underwent transcutaneous renal biopsy. In the 7 hemizygotes and one of the heterozygotes, light microscopy revealed diffuse characteristic vacuolisation of the glomerular cells. In the other heterozygote, the glomerular lesions were very limited, seen only by electron microscopy.


Asunto(s)
Enfermedad de Fabry/diagnóstico , Neoplasias Cutáneas/diagnóstico , Adolescente , Adulto , Biopsia con Aguja , Niño , Enfermedades de la Córnea/etiología , Extremidades , Enfermedad de Fabry/genética , Femenino , Galactosilgalactosilglucosilceramidasa/sangre , Genotipo , Humanos , Riñón/patología , Glomérulos Renales/ultraestructura , Leucocitos/enzimología , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Dolor/etiología , Linaje , Neoplasias Cutáneas/genética , Vacuolas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA